Orbit Discovery will be at BioEurope Spring 2026 in Lisbon, focusing on how it functional and affinity screening platforms unlock high-value hits for modalities like radiopharmaceuticals, oligonucleotide delivery and precision oncology.
Functional data early in discovery enables:
• Selection of mechanistically relevant hits
• Identification of agonists, antagonists and biased signalling peptides
• More confident progression into optimisation and in vivo studies
If you’re prioritising functional performance over simple binding, let’s meet in Lisbon and talk about how our platform can support your next programme.